# Dimension Inx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dimension-inx

- Industry: Biotechnology
- Headquarters: Chicago, US
- Website: www.dimensioninx.com
- Total disclosed funding: $12M
- Latest round: Series A (Jan 23, 2023)
- Investors on record: 6

## About

Based in Illinois, US, and founded in 2017, Dimension Inx, LLC designs and develops bioactive therapeutic products that restore tissue and organ function. In January 2023, the firm raised USD 12 million in series A funding led by investor Prime Movers Lab, with participation from investors KdT Ventures and Revolution Ventures.

The company through its biomaterials and manufacturing process develops and manufactures 3D-printed bioactive structures to drive bifunctionality and to treat human disease and debilitation including musculoskeletal health, and reproductive health. The company’s material provides a three-dimensional blueprint, that directs cells to behave as intended in bone regeneration, reproductive longevity, etc. Dimensions also work on the development of new materials for tissue therapeutics such as soft tissue restoration, and cell therapy delivery.

The business intends to use its January 2023 fundraising to advance therapeutic development as well as scale the introduction of the company's pipeline of tissue and organ implants.

## Funding rounds

- Series A, Jan 23, 2023, $12M — Revolution Ventures, Alumni Ventures Group, Solas BioVentures, KdT Ventures, Prime Movers Lab, Portal Innovations

## Investors

- Revolution Ventures (https://capitalatlas.ai/funds/revolution-ventures) — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Solas BioVentures (https://capitalatlas.ai/funds/solas-bioventures) — Series A
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Series A
- Prime Movers Lab (https://capitalatlas.ai/funds/prime-movers-lab) — Series A
- Portal Innovations (https://capitalatlas.ai/funds/portal-innovations) — Series A